148 related articles for article (PubMed ID: 4641757)
1. Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea.
Costanza ME; Nathanson L; Lenhard R; Wolter J; Colsky J; Oberfield RA; Schilling A
Cancer; 1972 Dec; 30(6):1457-61. PubMed ID: 4641757
[No Abstract] [Full Text] [Related]
2. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin.
Gutterman JU; Mavligit G; Gottlieb JA; Burgess MA; McBride CE; Einhorn L; Freireich EJ; Hersh EM
N Engl J Med; 1974 Sep; 291(12):592-7. PubMed ID: 4851001
[No Abstract] [Full Text] [Related]
3. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer.
Falkson G; van Eden EB; Falkson HC
Cancer; 1974 May; 33(5):1207-9. PubMed ID: 4595974
[No Abstract] [Full Text] [Related]
4. [Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma].
Beretta G; Bajetta E; Bonadonna G; Tancini G; Orefice S; Veronesi U
Tumori; 1973; 59(3):239-48. PubMed ID: 4729646
[No Abstract] [Full Text] [Related]
5. Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).
Hill GJ; Ruess R; Berris R; Philpott GW; Parkin P
Ann Surg; 1974 Aug; 180(2):167-74. PubMed ID: 4601984
[TBL] [Abstract][Full Text] [Related]
6. Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.
Gerner RE; Moore GE
Cancer Chemother Rep; 1973 Feb; 57(1):83-4. PubMed ID: 4704107
[No Abstract] [Full Text] [Related]
7. Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma.
Moon JH; Gailani S; Cooper MR; Hayes DM; Rege VB; Blom J; Falkson G; Maurice P; Brunner K; Glidewell O; Holland JF
Cancer; 1975 Feb; 35(2):368-71. PubMed ID: 1111913
[TBL] [Abstract][Full Text] [Related]
8. Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma.
Einhorn LH; McBride CM; Luce JK; Caoili E; Gottlieb JA
Cancer; 1973 Oct; 32(4):749-55. PubMed ID: 4751911
[No Abstract] [Full Text] [Related]
9. Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma.
Falkson G; Van der Merwe AM; Falkson HC
Cancer Chemother Rep; 1972 Oct; 56(5):671-7. PubMed ID: 4569061
[No Abstract] [Full Text] [Related]
10. [Chemotherapy of malignant melanoma].
Wagenknecht L
Schweiz Med Wochenschr; 1973 Oct; 103(41):1426-8. PubMed ID: 4127413
[No Abstract] [Full Text] [Related]
11. Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma.
Nathanson L; Wolter J; Horton J; Colsky J; Shnider BI; Schilling A
Clin Pharmacol Ther; 1971; 12(6):955-62. PubMed ID: 5134998
[No Abstract] [Full Text] [Related]
12. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
Ahmann DL; Hahn RG; Bisel HF
Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357
[No Abstract] [Full Text] [Related]
13. Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide.
Gottlieb JA; Baker LH; Quagliana JM; Luce JK; Whitecar JP; Sinkovics JG; Rivkin SE; Brownlee R; Frei E
Cancer; 1972 Dec; 30(6):1632-8. PubMed ID: 4663966
[No Abstract] [Full Text] [Related]
14. Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin.
Gerner RE; Moore GE; Didolkar MS
Cancer; 1973 Oct; 32(4):756-60. PubMed ID: 4751912
[No Abstract] [Full Text] [Related]
15. Combination chemotherapy for disseminated malignant melanoma.
Costanzi JJ; Vaitkevicius VK; Quagliana JM; Hoogstraten B; Coltman CA; Delaney FC
Cancer; 1975 Feb; 35(2):342-6. PubMed ID: 1111912
[TBL] [Abstract][Full Text] [Related]
16. [Imidazole carboxamide in the treatment of disseminated melanoblastoma].
Garin AM; Lichinitser MR; Moroz LV
Vopr Onkol; 1973; 19(11):3-7. PubMed ID: 4785973
[No Abstract] [Full Text] [Related]
17. Comparative studies on the chemical stability and therapeutic effectiveness of water-insoluble 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) and its water-soluble hydrochloride against L1210 mouse leukemia.
Woodman RJ; Kline I; Field RB; Gang M
Cancer Chemother Rep; 1973; 57(4):383-91. PubMed ID: 4762437
[No Abstract] [Full Text] [Related]
18. 5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of advanced acute lymphocytic leukemia in children.
Finklestein JZ; Albo V; Ertel I; Karon M; Hammond D
Cancer Chemother Rep; 1972 Aug; 56(4):523-6. PubMed ID: 4507686
[No Abstract] [Full Text] [Related]
19. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma.
Frei E; Luce JK; Talley RW; Vaitkevicius VK; Wilson HE
Cancer Chemother Rep; 1972 Oct; 56(5):667-70. PubMed ID: 4569060
[No Abstract] [Full Text] [Related]
20. Chemotherapy of malignant melanoma.
Luce JK
Cancer; 1972 Dec; 30(6):1604-15. PubMed ID: 4565819
[No Abstract] [Full Text] [Related]
[Next] [New Search]
